Correlation Between Virpax Pharmaceuticals and X4 Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both Virpax Pharmaceuticals and X4 Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Virpax Pharmaceuticals and X4 Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Virpax Pharmaceuticals and X4 Pharmaceuticals, you can compare the effects of market volatilities on Virpax Pharmaceuticals and X4 Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Virpax Pharmaceuticals with a short position of X4 Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of Virpax Pharmaceuticals and X4 Pharmaceuticals.
Diversification Opportunities for Virpax Pharmaceuticals and X4 Pharmaceuticals
0.91 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between Virpax and XFOR is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Virpax Pharmaceuticals and X4 Pharmaceuticals in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on X4 Pharmaceuticals and Virpax Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Virpax Pharmaceuticals are associated (or correlated) with X4 Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of X4 Pharmaceuticals has no effect on the direction of Virpax Pharmaceuticals i.e., Virpax Pharmaceuticals and X4 Pharmaceuticals go up and down completely randomly.
Pair Corralation between Virpax Pharmaceuticals and X4 Pharmaceuticals
Given the investment horizon of 90 days Virpax Pharmaceuticals is expected to under-perform the X4 Pharmaceuticals. In addition to that, Virpax Pharmaceuticals is 1.73 times more volatile than X4 Pharmaceuticals. It trades about -0.72 of its total potential returns per unit of risk. X4 Pharmaceuticals is currently generating about -0.3 per unit of volatility. If you would invest 35.00 in X4 Pharmaceuticals on January 6, 2025 and sell it today you would lose (13.00) from holding X4 Pharmaceuticals or give up 37.14% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
Virpax Pharmaceuticals vs. X4 Pharmaceuticals
Performance |
| Timeline |
| Virpax Pharmaceuticals |
| X4 Pharmaceuticals |
Virpax Pharmaceuticals and X4 Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Virpax Pharmaceuticals and X4 Pharmaceuticals
The main advantage of trading using opposite Virpax Pharmaceuticals and X4 Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Virpax Pharmaceuticals position performs unexpectedly, X4 Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in X4 Pharmaceuticals will offset losses from the drop in X4 Pharmaceuticals' long position.| Virpax Pharmaceuticals vs. Intracellular Th | Virpax Pharmaceuticals vs. Amphastar P | Virpax Pharmaceuticals vs. Assertio Therapeutics | Virpax Pharmaceuticals vs. ANI Pharmaceuticals |
| X4 Pharmaceuticals vs. Terns Pharmaceuticals | X4 Pharmaceuticals vs. Day One Biopharmaceuticals | X4 Pharmaceuticals vs. PDS Biotechnology Corp | X4 Pharmaceuticals vs. Inozyme Pharma |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Companies Directory module to evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals.
Other Complementary Tools
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Price Transformation Use Price Transformation models to analyze the depth of different equity instruments across global markets |